{"slug":"vip-nsaids","verification":{"valid":true,"entries":2,"head":"e2380dde7b144c6334d1dd9773e803aae69e8b1a9e6999ad8da81b48156102fa"},"energy":{"passes":2,"tokens_in":15161,"tokens_out":2957,"tokens_total":18118,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"e2380dde7b144c6334d1dd9773e803aae69e8b1a9e6999ad8da81b48156102fa"},"provenance":[{"ts":"2026-06-29T22:26:48.399Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Nsaids\nSlug: vip-nsaids\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"NSAIDs\",\"condition_key\":\"nsaids\",\"primary_peptide\":\"vip\",\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[\"nsaids\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have NSAIDs\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"You are reading about **NSAIDs** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"nsaids\",\"name\":\"NSAIDs\",\"section_title\":\"Why NSAIDs matters for you\",\"steps\":[\"**Drug:** NSAIDs\",\"**What it does:** Suppress inflammation signal; may slow structural repair cascade.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair for your condition.\"],\"prose\":\"1. **Drug:** NSAIDs\\n2. **What it does:** Suppress inflamma","response":"{\n  \"slug\": \"vip-nsaids\",\n  \"title\": \"VIP and NSAIDs: Preclinical Immune Modulation Data vs Inflammation Suppression\",\n  \"body\": \"## What's breaking down if you have NSAIDs\\n\\nNSAIDs primarily suppress inflammatory signals rather than support tissue repair cascades. This can reduce short-term symptoms but may trade off against longer structural recovery in some contexts. The focus here stays on that distinction: suppression versus repair pathways.\\n\\n## Why VIP might help you\\n\\n1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nVIP acts on immune and autonomic layers. If your NSAID use involves ongoing immune dysregulation or autonomic imbalance, the peptide's studied effects on cytokine balance and regulatory cells become relevant for repair-focused discussion.\\n\\n## Why NSAIDs matters for you\\n\\n**Drug:** NSAIDs\\n**What it does:** Suppress inflammation signal; may slow structural repair cascade.\\n**Therefore for you:** NSAIDs suppress a signal. This can ease mechanical symptoms but trades off against repair support in the layers discussed for VIP.\\n\\n## How these fit together\\n\\nSingle-compound focus — VIP targets the immune / autonomic layer. NSAIDs handle signal suppression. The stack_together note applies directly: siblings would target other layers if a multi-peptide profile existed, but here the mapping stays to immune/autonomic for VIP.\\n\\n## What the evidence actually shows\\n\\nHuman data on VIP specifically paired with NSAIDs remains absent in published trials (preclinical and mechanistic sources dominate). Animal models show VIP reducing inflammation markers in arthritis setups. Observational human notes link lower VIP levels to poorer arthritis outcomes. Reddit and X posts discuss VIP in chronic inflammation contexts but provide no controlled comparisons to NSAIDs.\\n\\n#","tokens_in":15161,"tokens_out":2957,"cost":0,"prev":"genesis","hash":"f81fa20abe8df99352024d6d41260f0accff534ba90039dff2fc73f9f5a17caa"},{"ts":"2026-07-17T02:43:25.834Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-nsaids","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f81fa20abe8df99352024d6d41260f0accff534ba90039dff2fc73f9f5a17caa","hash":"e2380dde7b144c6334d1dd9773e803aae69e8b1a9e6999ad8da81b48156102fa"}]}